Perzinfotel
Alternative Names: EAA-090; WAY-126090Latest Information Update: 05 Nov 2023
At a glance
- Originator Wyeth
- Class Amino acids; Neuroprotectants; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Neuropathic pain; Pain; Stroke
Most Recent Events
- 07 Aug 2009 Discontinued - Phase-II for Neuropathic pain in USA (IV)
- 07 Aug 2009 Discontinued - Phase-II for Pain in USA (IV)
- 07 Aug 2009 Discontinued - Preclinical for Stroke in USA (IV)